The ‘Global Top 10 Drug Delivery Technologies Market (2010 – 2015)’ analyzes the drug delivery technologies market by the top 10 drug delivery technologies and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and ROW.
Browse market data tables and in-depth TOC on Global Top 10 Drug Delivery Technologies Market: Global Forecast.
Early buyers will receive 10% customization on this report.
The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. The time release technologies market commands the largest share around 19% of the overall top 10 drug delivery technologies market, owing to immense popularity of once-daily formulations.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=112
Drug delivery technologies are revenue boosters for the pharmaceutical industry as they enhance drug life cycle in the market by extending patent rights, adding a competitive edge to the drug by enhancing their safety and efficacy. Further, expansion of the applications of non conventional modes of drug delivery such as pulmonary, nasal and transdermal in disease conditions other than respiratory and skin, especially in chronic disease conditions such as diabetes, CNS are also boosting the market. In addition, innovations such as microneedle transdermal patches and novel intelligent inhalers are also adding to the market growth. However, recent drug failures such as Exubera by Pfizer is a hindrance for the market.
Download Free PDF Brochure: http://www.marketsandmarkets.com/requestsample.asp?id=112
Prominent industry participants include Elan, Biovail, Nektar and Alkermes. Pure drug delivery technology providers are gradually shifting towards specialty pharmaceuticals with focus on CNS and Cancer. Further, industry players are focusing on developing alternatives that are not only safe and effective but also are convenient in terms of drug administration and dosing regimen.
Currently, market players are focusing in the development and commercialization of new drugs through agreements and collaborations which therefore accounted for the highest share of the total competitive developments in the global top 10 drug delivery technologies market from 2007 to June 2010.
Browse related reports:
Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors,
Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting
Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017
Injectable Drug Delivery Market by Formulations
[Liposomes, Microspheres, & Nanoparticles], Devices [Disposables &
Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors]
& Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Email: firstname.lastname@example.orgVisit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnologyConnect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets